A detailed history of Bank Of Montreal transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Bank Of Montreal holds 24,880 shares of PRTA stock, worth $499,341. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,880
Holding current value
$499,341
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$24.75 - $40.66 $615,780 - $1.01 Million
24,880 New
24,880 $616,000
Q2 2023

Aug 02, 2023

BUY
$48.26 - $78.59 $3.22 Million - $5.25 Million
66,767 New
66,767 $4.56 Million
Q2 2022

Aug 11, 2022

SELL
$22.73 - $39.98 $514,902 - $905,666
-22,653 Reduced 47.64%
24,893 $692,000
Q4 2021

Feb 11, 2022

BUY
$42.11 - $73.26 $1.1 Million - $1.91 Million
26,021 Added 120.89%
47,546 $2.28 Million
Q3 2021

Nov 12, 2021

BUY
$48.2 - $78.89 $1.04 Million - $1.7 Million
21,525 New
21,525 $1.56 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $942M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.